John Strumbos
Chief Executive Officer Mimetic Medicines
Seminars
Wednesday 23rd September 2026
Designing short lipidated peptides (SLiPs) to target intracellular drivers of disease
1:30 pm
- Scaffold proteins interact with ion channels to regulate neuronal activity
- Short lipidated peptides (SLiPs) can be engineered to disrupt pathological complexes between scaffold proteins and ion channels
- MM-3001 is a fast-onset, long-acting, investigational SLiP for the treatment of chronic pain
